论文信息 - Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma. - 字舞流文

Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma.

J. Utikal | D. Schadendorf | B. Schilling | J. Becker | S. Ugurel | R. Herbst | E. Livingstone | A. Sucker | L. Zimmer | P. Horn | C. Pföhler | A. Paschen | S. Schramm | V. Rebmann | K. Horny | C. Blank | Selma Ugurel | Sabine Schramm | D. Schadendorf | E. Livingstone | C. U. Blank | K. Horny | Rudolf A. Herbst | Jana Becker | Peter A. Horn